Page last updated: 2024-08-24

plerixafor and Esophageal Neoplasms

plerixafor has been researched along with Esophageal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dohrmann, T; Drenckhan, A; Effenberger, K; Forberich, E; Gros, SJ; Hoffman, RM; Izbicki, JR; Kaifi, JT; Kurschat, N; Pantel, K; Reichelt, U	1

Other Studies

1 other study(ies) available for plerixafor and Esophageal Neoplasms

Article	Year
Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer. PloS one, 2012, Volume: 7, Issue:10 Topics: Animals; Antibodies, Monoclonal, Humanized; Benzylamines; Body Weight; Bone Marrow; Cell Line, Tumor; Cell Movement; Cyclams; Disease Models, Animal; Esophageal Neoplasms; Female; Heterocyclic Compounds; Humans; Male; Mice; Neoplasm Metastasis; Receptor, ErbB-2; Receptors, CXCR4; Reproducibility of Results; Trastuzumab; Tumor Burden; Up-Regulation	2012

Article

Year

Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer.

PloS one, 2012, Volume: 7, Issue:10

Topics: Animals; Antibodies, Monoclonal, Humanized; Benzylamines; Body Weight; Bone Marrow; Cell Line, Tumor; Cell Movement; Cyclams; Disease Models, Animal; Esophageal Neoplasms; Female; Heterocyclic Compounds; Humans; Male; Mice; Neoplasm Metastasis; Receptor, ErbB-2; Receptors, CXCR4; Reproducibility of Results; Trastuzumab; Tumor Burden; Up-Regulation

2012